Reducing Complications in Esophagus Surgery

Esophageal cancer remains one of the most prevalent cancers globally and a leading cause of cancer-related mortality. Among the various treatments available, three-field lymphadenectomy has recently gained significant attention. Originating in Japan in the 1980s and now utilized in several other countries, it continues to be a topic of active discussion, especially in the context of contemporary neoadjuvant treatments. This upcoming webinar will bridge Japanese and European perspectives on this critical topic. We will explore best practices and review evidence on reducing complications, providing valuable insights for surgeons worldwide.

Clinical Background

1. JSES Introduction

2. Welcome & Introduction - Prof. Hiroya Takeuchi (Japan)

3. JCOG1409 (MONET Trial)  - Prof. Hiroya Takeuchi (Japan)

4. Precise Upper Mediastinal Dissection for Esophageal Cancer and Future Perspective of Three-Field Lymphadenectomy - Dr. Shigeru Tsunoda (Japan)

5. Treatment of Anastomotic Leakage after Esophagectomy - Prof. Dr. Richard van Hillegersberg (Netherlands)

6. Panel Discussion - All faculty moderated by Prof. Hiroya Takeuchi (Japan)

7. Closing Remarks -  Prof. Hiroya Takeuchi (Japan)